| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 69.194 | 78.269 | 78.807 | 80.429 | 76.273 | 74.756 | 72.774 | 89.826 | 97.038 | 96.496 |
| Total Income - EUR | 71.328 | 78.490 | 78.926 | 80.911 | 76.893 | 74.981 | 73.019 | 92.251 | 101.732 | 111.016 |
| Total Expenses - EUR | 10.855 | 14.002 | 11.465 | 11.269 | 10.107 | 15.824 | 24.019 | 23.726 | 24.896 | 24.841 |
| Gross Profit/Loss - EUR | 60.472 | 64.488 | 67.461 | 69.642 | 66.786 | 59.157 | 49.000 | 68.525 | 76.836 | 86.175 |
| Net Profit/Loss - EUR | 50.575 | 62.918 | 66.672 | 68.833 | 66.017 | 58.463 | 48.357 | 67.621 | 75.952 | 82.911 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Onco Inspire Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.628 | 2.245 | 2.207 | 2.166 | 2.124 | 51.513 | 37.482 | 24.669 | 11.705 | 2.026 |
| Current Assets | 147.253 | 128.590 | 159.081 | 182.260 | 205.961 | 174.851 | 203.473 | 276.238 | 292.148 | 399.974 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.822 | 6.680 | 6.567 | 7.473 | 6.743 | 6.617 | 6.469 | 56.228 | 8.491 | 61.598 |
| Cash | 141.431 | 121.909 | 152.513 | 174.788 | 199.218 | 168.234 | 197.004 | 220.010 | 283.657 | 97.811 |
| Shareholders Funds | 107.085 | 63.139 | 66.791 | 134.399 | 197.813 | 169.832 | 214.423 | 67.670 | 95.847 | 82.959 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 42.796 | 67.695 | 94.496 | 50.028 | 9.936 | 56.532 | 26.532 | 233.238 | 208.007 | 319.041 |
| Income in Advance | 0 | 0 | 0 | 0 | 337 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Onco Inspire Med Srl